I-Mab Financial Statements From 2010 to 2021

IMAB -  USA Stock  

USD 52.75  4.68  8.15%

I-Mab ADR financial statements provide useful quarterly and yearly information to potential I-Mab ADR investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on I-Mab ADR financial statements helps investors assess I-Mab ADR's valuation, profitability, and current liquidity needs.
We have found sixty-seven available fundamental trends for I-Mab ADR, which can be analyzed and compared to other ratios and to its competitors. Make sure you confirm all of I-Mab ADR regular market performance against the performance between 2010 and 2021 to make sure the company can sustain itself in the coming quarters.
The current year Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to grow to about 547.3 M. The current year Earnings before Tax is expected to grow to about 521.3 M.

I-Mab Financial Statements 

 
Refresh
Check I-Mab ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among I-Mab main balance sheet or income statement drivers, such as Consolidated Income of 508.1 M, Earning Before Interest and Taxes EBIT of 522.3 M or Gross Profit of 1.7 B, as well as many exotic indicators such as Asset Turnover of 0.41, Book Value per Share of 104 or Current Ratio of 7.92. I-Mab financial statements analysis is a perfect complement when working with I-Mab ADR Valuation or Volatility modules. It can also supplement various I-Mab ADR Technical models. Please see the analysis of I-Mab ADR Correlation against competitors.

I-Mab ADR Revenues

1.66 BillionShare

I-Mab ADR Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.8 B6.3 B2.1 B
Increasing
Slightly volatile
Cash and Equivalents5.1 B4.8 B1.3 B
Increasing
Slightly volatile
Investments751.3 M696.4 M322.1 M
Increasing
Slightly volatile
Investments Current32.4 M31.5 M206.8 M
Decreasing
Slightly volatile
Investments Non Current594.8 M598.3 M653.5 M
Decreasing
Slightly volatile
Deferred Revenue7.1 M7.5 M12.3 M
Decreasing
Slightly volatile
Deposit Liabilities12.7 M12.7 M13.9 M
Decreasing
Slightly volatile
Property Plant and Equipment Net41 M40.3 M27.8 M
Increasing
Slightly volatile
Trade and Non Trade Receivables351.7 M326 M83.6 M
Increasing
Slightly volatile
Trade and Non Trade Payables604.8 M560.6 M135.2 M
Increasing
Slightly volatile
Goodwill and Intangible Assets277.1 M283 M306.2 M
Decreasing
Slightly volatile
Total Liabilities675.8 M706.6 M411.6 M
Increasing
Slightly volatile
Shareholders Equity6.1 B5.6 B525.9 M
Increasing
Slightly volatile
Accumulated Other Comprehensive Income(52.1 M)(50.8 M)M
Decreasing
Stable
Current Assets5.8 B5.3 B1.7 B
Increasing
Slightly volatile
Assets Non Current816.3 M990.1 M432.6 M
Increasing
Slightly volatile
Current Liabilities550.1 M576.1 M301.8 M
Increasing
Slightly volatile
Liabilities Non Current125.7 M130.5 M109.8 M
Decreasing
Stable
Total Debt14 M13.6 M167.6 M
Decreasing
Slightly volatile
Debt Current8.3 M8.1 M78.8 M
Decreasing
Slightly volatile
Debt Non Current5.7 M5.5 M88.8 M
Decreasing
Slightly volatile
Shareholders Equity USD928.3 M860.4 M83.1 M
Increasing
Slightly volatile
Cash and Equivalents USD785.1 M727.6 M202.1 M
Increasing
Slightly volatile
Total Debt USD2.1 M2.1 M25.2 M
Decreasing
Slightly volatile

I-Mab ADR Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues1.7 B1.5 B281.9 M
Increasing
Slightly volatile
Selling General and Administrative Expense378.1 M402.4 M142.1 M
Increasing
Slightly volatile
Research and Development Expense882.7 M984.7 M439.2 M
Increasing
Slightly volatile
Operating Expenses988.9 M974.2 M526.3 M
Increasing
Slightly volatile
Interest Expense982.2 K957 K5.1 M
Decreasing
Slightly volatile
Income Tax Expense11.4 M14.1 M4.4 M
Increasing
Slightly volatile
Consolidated Income508.1 M470.9 M(271.8 M)
Increasing
Stable
Net Income508.1 M470.9 M(271.8 M)
Increasing
Stable
Preferred Dividends Income Statement Impact29.6 M29.7 M32.5 M
Decreasing
Slightly volatile
Net Income Common Stock508.1 M470.9 M(274.6 M)
Increasing
Stable
Weighted Average Shares144.8 M134.2 M28.2 M
Increasing
Slightly volatile
Weighted Average Shares Diluted169.6 M157.2 M32.2 M
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT522.3 M484.1 M(264.4 M)
Increasing
Stable
Revenues USD254.5 M235.9 M43 M
Increasing
Slightly volatile
Net Income Common Stock USD77.7 M72 M(40.1 M)
Increasing
Stable
Earning Before Interest and Taxes USD79.9 M74 M(38.6 M)
Increasing
Stable
Gross Profit1.7 B1.5 B281.9 M
Increasing
Slightly volatile
Operating Income613.3 M568.5 M(249.5 M)
Increasing
Stable

I-Mab ADR Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Business Acquisitions and Disposals(190 M)(185.1 M)(3.3 M)
Decreasing
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals10.5 M11.8 M(131.2 M)
Increasing
Slightly volatile
Net Cash Flow from Financing3.7 B3.4 B1.2 B
Increasing
Slightly volatile
Issuance Repayment of Debt Securities (51.3 M)(50 M)132.7 M
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares4.4 BBB
Increasing
Slightly volatile
Net Cash Flow from Investing(207.2 M)(201.9 M)(120.7 M)
Increasing
Stable
Net Cash Flow from Operations467.8 M433.6 M(188.7 M)
Increasing
Slightly volatile
Effect of Exchange Rate Changes on Cash (109.4 M)(106.6 M)(11.9 M)
Decreasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents3.8 B3.6 B915.2 M
Increasing
Slightly volatile
Share Based Compensation532.4 M493.5 M121.1 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion19 M23.1 M6.5 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share8.718.073(129)
Increasing
Very volatile
Earnings per Diluted Share7.456.9(129)
Increasing
Very volatile
Earnings per Basic Share USD1.331.234(19.0422)
Increasing
Very volatile
Return on Average Equity0.40.2620.6195
Decreasing
Stable
Return on Average Assets0.120.117(0.2178)
Increasing
Stable
Return on Invested Capital1.961.9125.4105
Increasing
Slightly volatile
Gross Margin0.890.90.9829
Decreasing
Slightly volatile
Profit Margin0.330.305(21.9017)
Increasing
Slightly volatile
EBITDA Margin0.360.329(21.3032)
Increasing
Slightly volatile
Return on Sales0.340.314(21.4539)
Increasing
Slightly volatile
Asset Turnover0.410.3820.0914
Increasing
Slightly volatile
Enterprise Value over EBITDA28.9629.1331.8128
Decreasing
Slightly volatile
Enterprise Value over EBIT30.4230.633.4184
Decreasing
Slightly volatile
Price to Earnings Ratio34.1834.3837.5441
Decreasing
Slightly volatile
Sales per Share3.414.0441.4274
Increasing
Slightly volatile
Price to Sales Ratio10.4310.4911.4593
Decreasing
Slightly volatile
Price to Book Value2.842.853.1147
Decreasing
Slightly volatile
Debt to Equity Ratio0.130.126(0.7292)
Increasing
Slightly volatile
Current Ratio7.929.2754.479
Increasing
Slightly volatile
Free Cash Flow per Share7.877.296(103)
Increasing
Stable
Book Value per Share10496.471(144)
Decreasing
Very volatile
Tangible Assets Book Value per Share106104306
Decreasing
Very volatile

I-Mab ADR Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax521.3 M483.1 M(269.5 M)
Increasing
Stable
Earnings Before Interest Taxes and Depreciation Amortization EBITDA547.3 M507.2 M(257.4 M)
Increasing
Stable
Earnings Before Interest Taxes and Depreciation Amortization USD83.7 M77.6 M(37.6 M)
Increasing
Stable
Market Capitalization2.4 B2.5 B2.7 B
Decreasing
Slightly volatile
Enterprise Value2.2 B2.3 B2.5 B
Decreasing
Slightly volatile
Invested Capital787.1 M729.5 M335.9 M
Increasing
Stable
Average Equity1.9 B1.8 B(284 M)
Increasing
Slightly volatile
Average Assets3.6 BB2.1 B
Increasing
Slightly volatile
Invested Capital Average227 M253.2 M227.2 M
Decreasing
Slightly volatile
Tangible Asset Value6.5 B6.1 B1.8 B
Increasing
Slightly volatile
Free Cash Flow459.1 M425.6 M(205.9 M)
Increasing
Slightly volatile
Working Capital5.1 B4.8 B1.4 B
Increasing
Slightly volatile

I-Mab Fundamental Market Drivers

Forward Price Earnings-38.79
Shares Short Prior Month2.16M
Average Daily Volume Last 10 Day458.09k
Average Daily Volume In Three Month518.97k
Date Short Interest15th of July 2021
Fifty Day Average65.65
Two Hundred Day Average65.99

I-Mab Upcoming Events

Upcoming Quarterly Report29th of March 2021
Next Fiscal Quarter End31st of December 2020
Next Fiscal Year End29th of March 2021
Last Quarter Report30th of September 2020
Last Earning Announcement31st of December 2019

About I-Mab ADR Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include I-Mab ADR income statement, its balance sheet, and the statement of cash flows. I-Mab ADR investors use historical funamental indicators, such as I-Mab ADR's revenue or net income, to determine how well the company is positioned to perform in the future. Although I-Mab ADR investors may use each financial statement separately, they are all related. The changes in I-Mab ADR's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on I-Mab ADR's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on I-Mab ADR Financial Statements. Understanding these patterns can help to make the right decision on long term investment in I-Mab ADR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Deferred Revenue7.5 M7.1 M
Revenues1.5 B1.7 B
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 228 people.

I-Mab ADR Investors Sentiment

The influence of I-Mab ADR's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in I-Mab. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

I-Mab ADR Implied Volatility

    
  55.08  
I-Mab ADR's implied volatility exposes the market's sentiment of I-Mab ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if I-Mab ADR's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that I-Mab ADR stock will not fluctuate a lot when I-Mab ADR's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards I-Mab ADR in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, I-Mab ADR's short interest history, or implied volatility extrapolated from I-Mab ADR options trading.

Current Sentiment - IMAB

I-Mab ADR Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in I-Mab ADR. What is your judgment towards investing in I-Mab ADR? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as I-Mab ADR using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of I-Mab ADR Correlation against competitors. Note that the I-Mab ADR information on this page should be used as a complementary analysis to other I-Mab ADR's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for I-Mab Stock analysis

When running I-Mab ADR price analysis, check to measure I-Mab ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy I-Mab ADR is operating at the current time. Most of I-Mab ADR's value examination focuses on studying past and present price action to predict the probability of I-Mab ADR's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move I-Mab ADR's price. Additionally, you may evaluate how the addition of I-Mab ADR to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is I-Mab ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of I-Mab ADR. If investors know I-Mab will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about I-Mab ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of I-Mab ADR is measured differently than its book value, which is the value of I-Mab that is recorded on the company's balance sheet. Investors also form their own opinion of I-Mab ADR's value that differs from its market value or its book value, called intrinsic value, which is I-Mab ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because I-Mab ADR's market value can be influenced by many factors that don't directly affect I-Mab ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between I-Mab ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine I-Mab ADR value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, I-Mab ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.